Why Static Biomarkers Often Fall Short: Circadian Immune Coherence as a Missing Dimension in Immunotherapy
F1000Research · 21.01.2026 · 15 · 98
DOI: 10.12688/f1000research.176828.1 ↗Kurz gefasst
Fachartikel in der Zeitschrift F1000Research, online erschienen am 21.01.2026. Verfasst von Ivan Bivolarski. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: No funding.
Abstract (Originalsprache)
Despite major advances in cancer immunotherapy, clinical decision-making still relies heavily on static biomarkers derived from single time-point measurements, such as PD-L1 expression or baseline inflammatory indices. While these markers provide partial prognostic and predictive information, they often fail to capture the dynamic and time-dependent nature of host–tumor immune interactions. Growing evidence from circadian biology demonstrates that immune cell trafficking, cytokine release, antigen presentation, and checkpoint pathway activity are subject to robust endogenous rhythmic regulation. Ignoring this temporal dimension may therefore lead to biological misclassification, inconsistent trial results, and suboptimal therapeutic scheduling. In this perspective, we argue that the limitations of static biomarkers arise not merely from technical insufficiency, but from a deeper conceptual gap: the absence of a system-level, time-aware framework capable of integrating longitudinal immune dynamics. We introduce Circadian Immune Coherence (CIC) as a systems-based property describing the alignment, stability, and rhythmic consistency of immune trajectories over time, rather than isolated absolute values. Drawing on circadian immunology, emerging data on immunotherapy timing, and advances in longitudinal analytical methods, we propose that CIC represents a missing conceptual dimension in immunotherapy research. Preliminary applications of this framework to longitudinal real-world clinical data (manuscript under review) support its operational feasibility and suggest the presence of distinct immune coherence phenotypes associated with immunotherapy outcomes. We discuss how time-series and spectral analytical approaches can operationalize CIC by uncovering latent rhythmic patterns in immune data that remain invisible to conventional static methods. Finally, we outline implications for biomarker development and clinical trial design, suggesting that time-aware stratification and adaptive scheduling may help reconcile conflicting results and improve therapeutic precision. We conclude that formally recognizing time as an intrinsic biological variable—and developing frameworks to measure its organization—is essential for moving beyond the limitations of static biomarkers.
Förderung
- No funding
Zitieren
APA
Bivolarski, I. (2026). Why Static Biomarkers Often Fall Short: Circadian Immune Coherence as a Missing Dimension in Immunotherapy. F1000Research, 15, 98. https://doi.org/10.12688/f1000research.176828.1
Vancouver
Bivolarski I. Why Static Biomarkers Often Fall Short: Circadian Immune Coherence as a Missing Dimension in Immunotherapy. F1000Research. 2026;15:98. doi:10.12688/f1000research.176828.1
BibTeX
@article{Bivolarski2026,
author = {Bivolarski, Ivan},
title = {Why Static Biomarkers Often Fall Short: Circadian Immune Coherence as a Missing Dimension in Immunotherapy},
journal = {F1000Research},
year = {2026},
volume = {15},
pages = {98},
doi = {10.12688/f1000research.176828.1}
}
EUVIMED